longbridge

002864

----

Panlong Pharmaceutical: Ketoprofen Gel Patch has received the Drug Clinical Trial Approval Notice

On February 11th, Jinshi Data reported that Panlong Pharmaceutical announced that the company received the "Drug Clinical Trial Approval Notice" issued by the National Medical Products Administration, agreeing to conduct clinical trials for Ketoprofen Gel Patch. Ketoprofen Gel Patch was first launched in Japan in 1988 by JOUWANG Pharmaceutical Co., Ltd. As of the date of this announcement, the original drug of Ketoprofen Gel Patch has not yet been launched in China, and only Hunan Jiudian Pharmaceutical Co., Ltd. has been approved for marketing by the National Medical Products Administration

Source: JIN10 The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy